Terms: = Sarcomas AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Diagnosis
10 results:
1. Risk Factors for Treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent Cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
[No Abstract] [Full Text] [Related]
2. The FBXO32/atr/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
[TBL] [Abstract] [Full Text] [Related]
3. High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma.
Knipprath-Mészáros AM; Tozzi A; Butenschön A; Reina H; Schoetzau A; Montavon C; Heinzelmann-Schwarz V; Manegold-Brauer G
Gynecol Oncol; 2023 Jul; 174():182-189. PubMed ID: 37210928
[TBL] [Abstract] [Full Text] [Related]
4. Sarcoma brain metastases: Tertiary cancer center experience.
Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
[TBL] [Abstract] [Full Text] [Related]
5. Inherited germline atrX mutation in two brothers with atr-X syndrome and osteosarcoma.
Ji J; Quindipan C; Parham D; Shen L; Ruble D; Bootwalla M; Maglinte DT; Gai X; Saitta SC; Biegel JA; Mascarenhas L
Am J Med Genet A; 2017 May; 173(5):1390-1395. PubMed ID: 28371217
[TBL] [Abstract] [Full Text] [Related]
6. Imaging investigations before referral to a sarcoma center delay the final diagnosis of musculoskeletal sarcoma.
Dyrop HB; Vedsted P; Rædkjær M; Safwat A; Keller J
Acta Orthop; 2017 Apr; 88(2):211-216. PubMed ID: 28077058
[TBL] [Abstract] [Full Text] [Related]
7. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract] [Full Text] [Related]
8. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
Amary MF; Berisha F; Mozela R; Gibbons R; Guttridge A; O'Donnell P; Baumhoer D; Tirabosco R; Flanagan AM
Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
[TBL] [Abstract] [Full Text] [Related]
9. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract] [Full Text] [Related]
10. A modified protocol with vincristine, topotecan, and cyclophosphamide for recurrent/progressive ewing sarcoma family tumors.
Kebudi R; Cakir FB; Gorgun O; Agaoglu FY; Darendeliler E
Pediatr Hematol Oncol; 2013 Apr; 30(3):170-7. PubMed ID: 23484903
[TBL] [Abstract] [Full Text] [Related]
